Chitosan-based gastrointestinal delivery systems

Journal of Controlled Release

Volumn 89, Issue 2, 2003, Pages 151-165

  Hejazi, Radi ^a   Amiji, Mansoor ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

Author keywords

Buccal; Chitosan; Colon specific; Drug delivery; Gene delivery; Intestinal; Oral; Stomach specific

Indexed keywords

ACETYLATION; BIOCOMPATIBILITY; BIODEGRADATION; CHITIN; GENES;

GASTROINTESTINAL DELIVERY SYSTEMS;

NATURAL POLYMERS;

2 HYDROXYETHYL METHACRYLATE; ALGINIC ACID; BUSERELIN; CALCIUM OXIDE; CELLABURATE; CELLACEFATE; CELLULOSE DERIVATIVE; CHITOSAN; CHITOSAN DERIVATIVE; CHLORHEXIDINE; CHONDROITIN SULFATE; DENTOSAN; DILTIAZEM; DRUG VEHICLE; ETHYL CELLULOSE; HYDROXYPROPYLMETHYLCELLULOSE; HYDROXYPROPYLMETHYLCELLULOSE ACETATE SUCCINATE; INULIN; MANNITOL; MESALAZINE; METHACRYLIC ACID; MICROCRYSTALLINE CELLULOSE; OCTREOTIDE; PECTIN; PEPTIDE; PHYTIC ACID CALCIUM MAGNESIUM SALT; POLYMER; PROTEIN; TETRACYCLINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZINC OXIDE;

COLON; DRUG ABSORPTION; DRUG CAPSULE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SYNTHESIS; DRUG TARGETING; GASTROINTESTINAL TRACT; GENE DELIVERY SYSTEM; HUMAN; IN VIVO STUDY; INTESTINE; MOUTH; MOUTHWASH; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REVIEW; STOMACH; STRUCTURE ANALYSIS; VACCINATION;

EID: 0037472115     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(03)00126-3     Document Type: Review

References (100)

1. Hoppe-Seiler F. Chitin and chitosan. Ber. Dtsch. Chem. Ges. 27:1994;3329-3331.
2. Roberts G.A.F. Solubility and solution behaviour of chitin and chitosan. Roberts G.A.F. Chitin Chemistry. 1992;274-329 MacMillan, Houndmills.
3. Domard A., Cartier N. Glucosamine oligomers: 4. Solid state-crystallization and sustained dissolution. Int. J. Biol. Macromol. 14:1992;100-106.
4. Roberts G.A.F. Structure of chitin and chitosan. Roberts G.A.F. Chitin Chemistry. 1992;1-53 MacMillan, Houndmills.
5. Kurita K. Chemical modifications of chitin and chitosan. Muzzarelli R.A.A., Jeuniaux C., Gooday G.W. Chitin in Nature and Technology. 1986;287-293 Plenum, New York.
6. Rha C.K., Rodriguez-Sanchez D., Kienzle-Sterzer C. Novel applications of chitosan. Colwell R.R., Pariser E.R., Sinskey A.J. Biotechnology of Marine Polysaccharides. 1984;284-311 Hemisphere, Washington.
7. Hirano S. Chitin biotechnology applications. Biotechnol. Annu. Rev. 2:1996;237-258.
8. Sannan T., Kurita K., Iwakura Y. Studies on chitin, 2. Effect of deacetylation on solubility. Macromol. Chem. 177:1976;3589-3600.
9. Amiji M.M., Patel V.R. Preparation and characterization of freeze-dried chitosan-poly(ethylene oxide) hydrogels for site-specific antibiotic delivery in the stomach. Pharm. Res. 13:1996;588-593.
10. Knapczyk J., Krowczynski L., Krzek J., Brzeski M., Nurnberg E., Schenk D., Struszczyk H. Requirements of chitosan for pharmaceutical and biomedical applications. Skjak-Braek G., Anthonsen T., Sandford P. Chitin and Chitosan-Sources, Chemistry, Biochemistry, Physical Properties and Applications. 1989;657-664 Elsevier, London.
11. Sandford P.A. Chitosan: commercial uses and potential applications. Skjak-Braek G., Anthonsen T., Sandford P. Chitin and Chitosan-Sources, Chemistry, Biochemistry, Physical Properties and Applications. 1989;51-69 Elsevier, London.
12. Errington N., Harding S.E., Varum K.M., Illum L. Hydrodynamic characterization of chitosans varying in degree of acetylation. Int. J. Biol. Macromol. 15:1993;113-117.
13. Fukuda H. Polyelectrolyte complexes of chitosan with sodium carboxymethylcellulose. Bull. Chem. Soc. Jpn. 53:1980;837-840.
14. Fukuda H., Kikuchi Y. Polyelectrolyte complexes of chitosan with sodium carboxymethyldextran. Bull. Chem. Soc. Jpn. 51:1978;1142-1144.
15. Illum L. Chitosan and its use as a pharmaceutical excipient. Pharm. Res. 15:1998;1326-1331.
16. Muzzarelli R.A.A. Stereochemistry and physical characterization. Muzzarelli R.A.A. Chitin. 1977;45-86 Pergamon, Oxford.
17. Chen R.H., Lin J.H., Yang M.H. Relationships between the chain flexibilities of chitosan molecules and the physical properties of their casted films. Carbohydr. Polymers. 24:1994;41-46.
18. Struszczyk H., Wawro D., Niekraszewicz A. Biodegradability of chitosan fibres. Brine C.J., Sandford P.A., Zikakis J.P. Advances in Chitin and Chitosan. 1991;580-585 Elsevier Applied Science, London.
19. Chandy T., Sharma C.P. Chitosan-as a biomaterial. Biomat. Art. Cells Art. Org. 18:1990;1-24.
20. Hirano S., Seino H., Akiyama Y., Nonaka I. Chitosan: a biocompatible material for oral and intravenous administrations. Gebelein C.G., Dunn R.L. Progress in Biomedical Polymers. 1990;283-290 Plenum, New York.
21. Knapczk J., Krowczynski L., Pawlik B., Liber Z. Pharmaceutical dosage forms with chitosan. Skjak-Braek G., Anthonsen T., Sandford P. Chitin and Chitosan: Sources, Chemistry, Biochemistry, Physical Properties and Applications. 1984;665-669 Elsevier Applied Science, London.
22. Sandford P.A. Chitosan and alginate: new forms of commercial interest. Am. Chem. Soc. Div. Polym. Chem. 31:1990;628-629.
23. Genco R.J. Antibiotics in the treatment of human periodontal disease. J. Periodontol. 52:1981;545-558.
24. Golomb G., Friedman M., Soskolne A., Stabholz A., Sela M.N. Sustained release device containing metronidazole for periodontal use. J. Dent. Res. 63:1984;1149-1153.
25. Robinson J.R. Rationale of bioadhesion/mucoadhesion. Gurny R., Junginger H.E. Bioadhesion: Possibilities and Future Trends. 1990;13-15 Wissenschaftliche, Stuttgart.
26. Needleman I.G., Martin G.P., Smales F.C. Characterization of bioadhesive for periodontal and oral mucosal drug delivery. J. Clin. Periodontol. 25:1998;74-82.
27. Şenel S., Kremer M.J., Kas S., Wertz P.W., Hincal A.A., Squier C.A. Enhancing effect of chitosan on peptide drug delivery across buccal mucosa. Biomaterials. 21:2000;2067-2071.
28. Staroniewicz Z., Ramisz A., Wojtasz-Pajak A., Brzeski M.M. Studies on antibacterial and antifungal activity of chitosan. Karnicki Z.S., Brzeski M.M., Bykowski P.J., Wojtasz-Pajak A. Chitin World. 1994;374-377 Wirtschaftverlag, Germany.
29. Seo H., Shoji A., Itoh Y., Kawamura M., Sakagami Y. Antibacterial fiber blended with chitosan. Karnicki Z.S., Brzeski M.M., Bykowski P.J., Wojtasz-Pajak A. Chitin World. 1994;623-631 Wirtschaftverlag, Germany.
30. Oglivie A., Frank R.M., Benque E.P., Gineste M., Heughebaert M., Hemmerle J. The biocompatibility of hydroxyapatite implanted in the human periodontum. J. Periodontal Res. 22:1987;270-283.
31. Cranin A.N., Tobin G.P., Gelbman J. Applications of hydroxylapatite in oral and maxillofacial surgery. I. Periodontal and endosteal implant repairs. Compend. Contin. Educ. Dent. 8:1987;254-256.
32. Denissen H.W., de Groot K. Immediate dental implants from synthetic dense calcium hydroxylapatite. J. Prosthet. Dent. 42:1979;551-556.
33. Scheer P., Boyne P.J. Maintenance of alveolar bone through implantation of bone graft substitutes in tooth extraction sockets. J. Am. Dent. Assoc. 114:1987;594-597.
34. Cranin A.N., Tobin G.P., Gelbman J. Applications of hydroxylapatite in oral and maxillofacial surgery. II. Ridge augmentation and repair of major oral defects. Compend. Contin. Educ. Dent. 8:1987;334-335. also see pp. 337-338, 340, 342-344.
35. Kent J.N., Quinn J.H., Zide M.F., Finger I.M., Jarcho M., Rothstein S.S. Correction of alveolar ridge deficiencies with non-resorbable hydroxylapatite. J. Am. Dent. Assoc. 105:1982;993-1001.
36. Larsen H.D., Finger I.M., Guerra L.R., Kent J.N. Prosthodontic management of the hydroxylapatite denture patient: a preliminary report. J. Prosthet. Dent. 49:1983;461-470.
37. Rothstein S.S., Paris D.A., Zacek M.P. Use of hydroxylapatite for the augmentation of deficient alveolar ridges. J. Oral Maxillofac. Surg. 42:1984;224-230.
38. Takagi Y. Failure cases of alveoloaugmentation with hydroxyapatite ceramics. Nihon Shika Hyoron. 543:1988;57-68.
39. Ito M. In vitro properties of a chitosan-bonded hydroxyapatite bone-filling paste. Biomaterials. 12:1991;41-45.
40. Misiek D.J., Kent J.M., Carr R.F. Soft tissue responses to hydroxylapatite particles of different shapes. J. Oral Maxillofac. Surg. 42:1984;150-160.
41. Nesbitt W.E., Doyle R.J., Tayler K.G. Hydrophobic interactions and the adherence of Streptococcus sanguis to hydroxyapatite. Infect. Immunol. 38:1982;637-644.
42. Rolla G., Robrish S.A., Bowen W.H. Interaction of hydroxyapatite and protein-coated hydroxyapatite with Streptococcus mutants and Streptococcus sanguis. Acta Path. Microbiol. Scand. Sec. B35:1977;341-346.
43. Sano H., Shibasaki K.I., Matsukubo T., Takaesu Y. Effect of rinsing with phosphorylated chitosan on 4-day plaque regrowth. Bull. Tokyo Dent. Coll. 42:2001;251-256.
44. Harris D., Robinson J.R. Drug delivery via the mucous membranes of the oral cavity. J. Pharm. Sci. 81:1992;1-10.
45. Nagai T., Machida Y. Buccal delivery systems using hydrogels. Adv. Drug Deliv. Rev. 11:1993;179-191.
46. Anders R., Merkle H.P. Evaluation of laminated mucoadhesive patches for buccal drug delivery. Int. J. Pharm. 49:1989;231-240.
47. Kockisch S., Rees G.D., Young S.A., Tsibouklis J., Smart J.D. A direct-staining method to evaluate the mucoadhesion of polymers from aqueous dispersion. J. Controlled Release. 77:2001;1-6.
48. Giunchedi P., Juliano C., Gavini E., Cossu M., Sorrenti M. Formulation and in vivo evaluation of chlorhexidine buccal tablets prepared using drug-loaded chitosan microspheres. Eur. J. Pharm. Biopharm. 53:2002;233-239.
49. Miyazaki S., Nakayama A., Oda M., Takada M., Attwood D. Drug release from oral mucosal adhesive tablets of chitosan and sodium alginate. Int. J. Pharm. 118:1995;257-263.
50. Minami H., McCallum R.W. The physiology and pathophysiology of gastric emptying in humans. Gastroenterology. 86:1984;1592-1610.
51. Cardinal J.R. Controlled drug delivery: veterinary applications. J. Controlled Release. 2:1985;393-403.
52. Hwang S.J., Park H., Park K. Gastric retentive drug-delivery systems. Crit. Rev. Ther. Drug Carrier Syst. 15:1998;243-284.
53. Machida Y., Nagai T., Inouye K., Sannan T. Preparation and evaluation of buoyant sustained release dosage forms based on chitosan. Skjak-Braek G., Anthonsen T., Sandford P. Chitin and Chitosan-Sources, Chemistry, Biochemistry, Physical Properties and Applications. 1989;693-702 Elsevier, London.
54. Miyazaki S., Yamaguchi H., Yokouchi C., Takada M., Hou W.M. Sustained-release and intragastric-floating granules of indomethacin using chitosan in rabbits. Chem. Pharm. Bull. 36:1988;4033-4038.
55. Schnürch A.B., Kast C.E. Chemically modified chitosans as enzyme inhibitors. Adv. Drug Deliv. Rev. 52:2001;127-137.
56. Yokel R.A., Dickey K.M., Goldberg A.H. Selective adherence of a sucralfate-tetracycline complex to gastric ulcers: implications for the treatment of Helicobacter pylori. Biopharm. Drug Dispos. 16:1995;475-479.
57. Shah S., Qaqish R., Patel V., Amiji M. Evaluation of the factors influencing stomach-specific delivery of antibacterial agents for Helicobacter pylori infection. J. Pharm. Pharmacol. 51:1999;667-672.
58. Hejazi R., Amiji M. Stomach-specific anti-H. pylori therapy. I: Preparation and characterization of tetracycline-loaded chitosan microspheres. Int. J. Pharm. 235:2002;87-94.
59. Genta I., Conti B., Perugini P., Pavanetto F., Spadaro A., Puglisi G. Bioadhesive microspheres for ophthalmic administration of acyclovir. J. Pharm. Pharmacol. 49:1997;737-742.
60. Henriksen I., Green K.L., Smart J.D., Smistad G., Karlsen J. Bioadhesion of hydrated chitosans: an in vitro and in vivo study. Int. J. Pharm. 145:1996;231-240.
61. Takeuchi H., Yamamoto H., Niwa T., Hino T., Kawashima Y. Enteral absorption of insulin in rats from mucoadhesive chitosan-coated liposomes. Pharm. Res. 13:1996;896-901.
62. Remuñan-López C., Portero A., Lemos M., Vila-Jato J.L., Nuñez M.J., Riveiro P., López J.M., Piso M., Alonso M.J. Chitosan microspheres for the specific delivery of amoxycillin to the gastric cavity. Stp Pharma Sci. 10:2000;69-76.
63. Behr J.P. Synthetic gene transfer vectors. Acc. Chem. Res. 26:1993;274-278.
64. Mulligan R.C. The basic science of gene therapy. Science. 260:1993;926-932.
65. Friedmann T. Human gene therapy-an immune genie, but certainly out of the bottle. Nat. Med. 2:1996;144-147.
66. Crystal R.G. The gene as the drug. Nat. Med. 1:1995;15-17.
67. Miller A.D. Human gene therapy comes of age. Nature. 357:1992;455-460.
68. Xiang Z.Q., Yang Y., Wilson J.M., Ertl H.C. A replication defective human adenovirus recombinant serves as a highly efficacious vaccine carrier. Virology. 219:1996;220-227.
69. Knowles M.R., Hohneker K.W., Zhou Z., Olsen J.C., Noah T.L., Hu P.C., Leigh M.W., Engelhardt J.F., Edwards L.J., Jones K.R. A controlled study of adenoviral vector-mediated gene transfer in the nasal epithelial of patients with cystic fibrosis. N. Engl. J. Med. 333:1995;823-831.
70. Alton E.W., Geddes D.M. Gene therapy for cystic fibrosis: a clinical perspective. Gene Ther. 2:1995;88-95.
71. Kim J.S., Maruyama A., Akaike T., Kim S.W. In vitro gene expression on smooth muscle cells using a terplex delivery system. J. Controlled Release. 47:1997;51-59.
72. Chang P.L., Shen N., Westcott A.J. Delivery of recombinant gene products with microencapsulated cells in vivo. Hum. Gene Ther. 4:1993;433-440.
73. Lee K.Y., Kwon I.C., Kim Y.H., Jo W.H., Jeong S.Y. Preparation of chitosan self aggregates as a gene delivery system. J. Controlled Release. 51:1998;213-220.
74. Leong K.W., Mao H.Q., Truong-Le V.L., Roy K., Walsh S.M., August J.T. DNA-polycation nanospheres as non-viral gene delivery vehicles. J. Controlled Release. 53:1998;183-193.
75. MacLaughlin F.C., Mumper R.J., Wang J., Tagliaferri J.M., Gill I., Hinchcliffe M., Rollad A.P. Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery. J. Controlled Release. 56:1998;259-272.
76. Roy K., Mao H.Q., Huang S.K., Leong K.W. Oral gene delivery with chitosan-DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat. Med. 5:1999;387-391.
77. van der Lubben I.M., Verhoef J.C., van Aelst A.C., Borchard G., Junginger H.E. Chitosan microparticles for oral vaccination: preparation, characterization and preliminary in vivo uptake studies in murine Peyer's patches. Biomaterials. 22:2001;687-694.
78. Aizpurua H.J., Russell-Jones G.J. Identification of classes of proteins that provoke an immune response upon oral feeding. J. Exp. Med. 67:1988;440-451.
79. Shalaby W.S.W. Development of oral vaccines to stimulate mucosal and systemic immunity: barriers and novel strategies. Clin. Immunol. Immunopathol. 74:1995;127-134.
80. Kofler N., Ruedl C., Rieser C., Wick G., Wolf H. Oral immunization with poly-(D,L-lactide-co-glycolide) and poly-(L-lactic acid) microspheres containing pneumotropic bacterial antigens. Int. Arch. Allergy Immunol. 113:1997;424-431.
81. Eldridge J.H., Hammond C.J., Meulbroek J.A., Staas J.K., Gilley R.M., Tice T.R. Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target Peyer's patches. J. Controlled Release. 11:1990;205-214.
82. Langer R. Drug delivery and targeting. Nature. 392:1998;5-10.
83. Aungst B.J. Novel formulation strategies for improving oral bioavailability of drugs with poor membrane permeation or presystemic metabolism. J. Pharm. Sci. 82:1993;979-987.
84. Lueßen H.L., de Leeuw B.J., Langemeyer M.W.E., de Boer A.G., Verhoef J.C., Junginger H.E. Mucoadhesive polymers in peroral peptide drug delivery. VI. Carbomer and chitosan improve the intestinal absorption of the peptide drug buserelin in vivo. Pharm. Res. 13:1996;1668-1672.
85. Thanou M., Verhoef J.C., Marbach P., Junginger H.E. Intestinal absorption of octreotide: N-trimethyl chitosan chloride (TMC) ameliorates the permeability and absorption properties of the somatostatin analogue in vitro and in vivo. J. Pharm. Sci. 89:2000;951-957.
86. Tozaki H., Komoike J., Tada C., Maruyama T., Terabe A., Suzuki T., Yamamoto A., Muranishi S. Chitosan capsules for colon-specific drug delivery: improvement of insulin absorption from the rat colon. J. Pharm. Sci. 86:1997;1016-1021.
87. Davaran S., Hanaee J., Khosravi A. Release of 5-amino salicylic acid from acrylic type polymeric prodrugs designed for colon-specific drug delivery. J. Controlled Release. 58:1999;279-287.
88. Cheng C.L., Gehrke S.H., Ritschel W.A. Development of an azopolymer based colonic release capsule for delivering proteins/macromolecules. Methods Find. Exp. Clin. Pharmacol. 16:1994;271-278.
89. Vervoort L., Vinckier I., Moldenaers P., Van den Mooter G., Augustijns P., Kinget R. Inulin hydrogels as carriers for colonic drug targeting. Rheological characterization of the hydrogel formation and the hydrogel network. J. Pharm. Sci. 88:1999;209-214.
90. Lin S.Y., Ayres J.W. Calcium alginate beads as core carriers of 5-aminosalicylic acid. Pharm. Res. 9:1992;1128-1131.
91. Marvola M., Nykanen P., Rautio S., Isonen N., Autere A. Enteric polymers as binders and coating materials in multiple-unit site-specific drug delivery systems. Eur. J. Pharm. Sci. 7:1999;259-267.
92. Rodriguez M., Vila Jato J.L., Torres D. Design of a new multiparticulate system for potential site-specific and controlled drug delivery to the colonic region. J. Controlled Release. 55:1998;67-77.
93. Ashford M., Fell J., Attwood D., Sharma H., Woodhead P. An evaluation of pectin as a carrier for drug targeting to the colon. J. Controlled Release. 26:1993;213-220.
94. Ashford M., Fell J., Attwood D., Sharma H., Woodhead P. Studies on pectin formulations for colonic drug delivery. J. Controlled Release. 30:1994;225-232.
95. Rubinstein A., Nakar D., Sintov A. Colonic drug delivery: enhanced release of indomethacin from cross-linked chondroitin matrix in rat cecal content. Pharm. Res. 9:1992;276-278.
96. Tozaki H., Fujita T., Odoriba T., Terabe A., Suzuki T., Tanaka C., Okabe S., Muranishi S., Yamamoto A. Colon-specific delivery of R68070, a new thromboxane synthase inhibitor, using chitosan capsules: therapeutic effects against 2,4,6-trinitrobenzene sulfonic acid-induced ulcerative colitis in rats. Life Sci. 64:1999;1155-1162.
97. Tozaki H., Odoriba T., Okada N., Fujita T., Terabe A., Suzuki T., Okabe S., Muranishi S., Yamamoto A. Chitosan capsules for colon-specific drug delivery: enhanced localization of 5-aminosalicylic acid in the large intestine accelerates healing of TNBS-induced colitis in rats. J. Controlled Release. 82:2002;51-61.
98. S. Tominaga, T. Takaizawa, M. Yamada, Colon drug delivery system, J. Pol. Appl. (1998) JP 10 324, 642 (98324,642) (C1 A61K47/36).
99. Macleod G.S., Fell J.T., Collett J.H., Sharma H.L., Smith A.M. Selective drug delivery to the colon using pectin:chitosan:hydroxypropyl methylcellulose film coated tablets. Int. J. Pharm. 187:1999;251-257.
100. Raghavan C.V., Muthulingam C., Amaladoss J., Jenita J.L., Ravi T.K. An in vitro and in vivo investigation into the suitability of bacterially triggered delivery system for colon targeting. Chem. Pharm. Bull. 50:2002;892-895.